APA (7th ed.) Citation

Lorusso, D., Guy, H., Samyshkin, Y., Hawkes, C., Estenson, K., & Coleman, R. L. (2022). Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer. Cancers, 14(5), 1285. https://doi.org/10.3390/cancers14051285

Chicago Style (17th ed.) Citation

Lorusso, Domenica, Holly Guy, Yevgeniy Samyshkin, Carol Hawkes, Kasey Estenson, and Robert L. Coleman. "Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer." Cancers 14, no. 5 (2022): 1285. https://doi.org/10.3390/cancers14051285.

MLA (9th ed.) Citation

Lorusso, Domenica, et al. "Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer." Cancers, vol. 14, no. 5, 2022, p. 1285, https://doi.org/10.3390/cancers14051285.